Sector revisions GSK plc

Equities

Market Closed - London S.E. Other stock markets 19:35:19 15/05/2026 +04			5-day change	1st Jan Change
1,862.50 ^GBX	-0.53%		+1.06%	+2.08%

05-15	WINNERS & LOSERS: Miners slide; Centrica to pay GBP20 million to Ofgem	AN
05-14	Morningstar Upgrades GSK to Buy Rating	MT

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	GSK PLC							20
	ELI LILLY AND COMPANY							29
	JOHNSON & JOHNSON							24
	ABBVIE INC.							29
	ROCHE HOLDING AG							17
	ASTRAZENECA PLC							21
	NOVARTIS AG							21
	MERCK & CO., INC.							27
	NOVO NORDISK A/S							23
	AMGEN INC.							30
	GILEAD SCIENCES, INC.							28
	PFIZER INC.							27
	BRISTOL-MYERS SQUIBB COMPANY							25
	VERTEX PHARMACEUTICALS INCORPORATED							28
	SANOFI							23
	CHUGAI PHARMACEUTICAL CO., LTD.							15
	JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD							17
	TAKEDA PHARMACEUTICAL COMPANY LIMITED							15
	BAYER AG							19
	TEVA PHARMACEUTICAL INDUSTRIES LIMITED							11
	Average							22
	Weighted average by Cap.							25